The most recognised kallikrein is KLK3, also known as prostate-specific antigen, which is an established biomarker for detecting or monitoring prostate cancer progression and response to treatment (Magklara et al, 1999; Stephan et al, 2002). This evidence concerns the gene KLK3 and prostate cancer.